| Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2 M Catanzaro, F Fagiani, M Racchi, E Corsini, S Govoni, C Lanni Signal transduction and targeted therapy 5 (1), 84, 2020 | 635 | 2020 |
| Immunomodulators inspired by nature: a review on curcumin and echinacea M Catanzaro, E Corsini, M Rosini, M Racchi, C Lanni Molecules 23 (11), 2778, 2018 | 307 | 2018 |
| Curcumin in Alzheimer’s disease: Can we think to new strategies and perspectives for this molecule? MM Serafini, M Catanzaro, M Rosini, M Racchi, C Lanni Pharmacological research 124, 146-155, 2017 | 111 | 2017 |
| Modulation of Keap1/Nrf2/ARE signaling pathway by curcuma-and garlic-derived hybrids MM Serafini, M Catanzaro, F Fagiani, E Simoni, R Caporaso, M Dacrema, ... Frontiers in Pharmacology 10, 1597, 2020 | 52 | 2020 |
| Merging memantine and ferulic acid to probe connections between NMDA receptors, oxidative stress and amyloid-β peptide in Alzheimer's disease M Rosini, E Simoni, R Caporaso, F Basagni, M Catanzaro, IF Abu, ... European journal of medicinal chemistry 180, 111-120, 2019 | 48 | 2019 |
| The role of chitosan as coating material for nanostructured lipid carriers for skin delivery of fucoxanthin LM Cordenonsi, A Faccendini, M Catanzaro, MC Bonferoni, S Rossi, ... International journal of pharmaceutics 567, 118487, 2019 | 46 | 2019 |
| Characterization of the antioxidant effects of γ-oryzanol: involvement of the Nrf2 pathway W Rungratanawanich, G Abate, MM Serafini, M Guarienti, M Catanzaro, ... Oxidative Medicine and Cellular Longevity 2018, 2018 | 39 | 2018 |
| Targeting infectious agents as a therapeutic strategy in Alzheimer’s disease T Fülöp, U Munawara, A Larbi, M Desroches, S Rodrigues, M Catanzaro, ... CNS drugs 34, 673-695, 2020 | 32 | 2020 |
| Prenylated curcumin analogues as multipotent tools to tackle Alzheimer’s disease F Bisceglia, F Seghetti, M Serra, M Zusso, S Gervasoni, L Verga, G Vistoli, ... ACS Chemical Neuroscience 10 (3), 1420-1433, 2018 | 29* | 2018 |
| Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2 F Fagiani, M Catanzaro, C Lanni Signal Transduction and Targeted Therapy 5 (1), 170, 2020 | 23 | 2020 |
| Eye-light on age-related macular degeneration: Targeting Nrf2-pathway as a novel therapeutic strategy for retinal pigment epithelium M Catanzaro, C Lanni, F Basagni, M Rosini, S Govoni, M Amadio Frontiers in Pharmacology 11, 547083, 2020 | 21 | 2020 |
| Targeting cytokine release through the differential modulation of Nrf2 and NF-κB pathways by electrophilic/non-electrophilic compounds F Fagiani, M Catanzaro, E Buoso, F Basagni, D Di Marino, S Raniolo, ... Frontiers in pharmacology 11, 574019, 2020 | 16 | 2020 |
| Characterization of antioxidant and anti-inflammatory profiles of new electrophilic/non-electrophilic compounds: relevance for Nrf2/NF-κB transcription factors involvement M Catanzaro Università degli studi di Pavia, 2020 | | 2020 |
| Molecular features of IGHV3-53-encoded antibodies elicited by SARS-CoV-2 F Francesca, M Catanzaro, C Lanni Signal Transduction and Targeted Therapy 5 (1), 2020 | | 2020 |
| MEMANTINE-FERULIC ACID HYBRIDS AS MOLECULAR PROBES FOR THE STUDY OF ALZHEIMER’S DISEASE F Basagni, R Caporaso, IF Abu, M Catanzaro, E Simoni, F Fusco, ... | | |
